Dilrini K. Ranatunga

2.4k total citations
23 papers, 682 citations indexed

About

Dilrini K. Ranatunga is a scholar working on Genetics, Molecular Biology and Surgery. According to data from OpenAlex, Dilrini K. Ranatunga has authored 23 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 5 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Dilrini K. Ranatunga's work include Genetic Associations and Epidemiology (8 papers), Lipoproteins and Cardiovascular Health (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Dilrini K. Ranatunga is often cited by papers focused on Genetic Associations and Epidemiology (8 papers), Lipoproteins and Cardiovascular Health (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Dilrini K. Ranatunga collaborates with scholars based in United States, Poland and Switzerland. Dilrini K. Ranatunga's co-authors include Catherine Schaefer, Neil Risch, Thomas J. Hoffmann, Carlos Iribarren, Pui–Yan Kwok, Eric Jorgenson, Priyanka Nandakumar, Georg Ehret, Aravinda Chakravarti and Marisa W. Medina and has published in prestigious journals such as Nature Genetics, Human Molecular Genetics and Medical Care.

In The Last Decade

Dilrini K. Ranatunga

23 papers receiving 672 citations

Peers

Countries citing papers authored by Dilrini K. Ranatunga

Since Specialization

Citations

This map shows the geographic impact of Dilrini K. Ranatunga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dilrini K. Ranatunga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dilrini K. Ranatunga more than expected).

Fields of papers citing papers by Dilrini K. Ranatunga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dilrini K. Ranatunga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dilrini K. Ranatunga. The network helps show where Dilrini K. Ranatunga may publish in the future.

Co-authorship network of co-authors of Dilrini K. Ranatunga

This figure shows the co-authorship network connecting the top 25 collaborators of Dilrini K. Ranatunga. A scholar is included among the top collaborators of Dilrini K. Ranatunga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dilrini K. Ranatunga. Dilrini K. Ranatunga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Metformin Cessation and Dementia Incidence 2023 ·JAMA Network Open ·Scott C. Zimmerman, (unknown), (unknown), Dilrini K. Ranatunga, Akinyemi Oni‐Orisan, Eleanor Hayes‐Larson, Aline Duarte Folle, Elizabeth Rose Mayeda, Rachel A. Whitmer, Paola Gilsanz, Melinda C. Power, Catherine Schaefer, M. Maria Glymour, Sarah F. Ackley	17
2	Telephone-based social health screening by pharmacists in the nonadherent Medicare population 2023 ·Journal of Managed Care & Specialty Pharmacy ·(unknown), Christopher Chang, K.L. Lo, (unknown), Connie S. Uratsu, (unknown), Dilrini K. Ranatunga, Richard W. Grant, (unknown)	2
3	Polygenic Risk Score and Statin Relative Risk Reduction for Primary Prevention of Myocardial Infarction in a Real‐World Population 2022 ·Clinical Pharmacology & Therapeutics ·Akinyemi Oni‐Orisan, Tanushree Haldar, (unknown), Dilrini K. Ranatunga, Thomas J. Hoffmann, Carlos Iribarren, Ronald M. Krauss, Neil Risch	11
4	UACA locus is associated with breast cancer chemoresistance and survival 2022 ·npj Breast Cancer ·Qianqian Zhu, Emily Schultz, Jirong Long, Janise M. Roh, Emily Valice, Cecile A. Laurent, (unknown), Li Yan, Isaac J. Ergas, Warren Davis, Dilrini K. Ranatunga, Shipra Gandhi, Marilyn L. Kwan, Ping‐Ping Bao, Wei Zheng, Xiao‐Ou Shu, Christine B. Ambrosone, Song Yao, Lawrence H. Kushi	5
5	Analysis of putative cis-regulatory elements regulating blood pressure variation 2020 ·Human Molecular Genetics ·Priyanka Nandakumar, Dongwon Lee, Thomas J. Hoffmann, Georg Ehret, Dan E. Arking, Dilrini K. Ranatunga, Man Li, Megan L. Grove, Eric Boerwinkle, Catherine Schaefer, Pui–Yan Kwok, Carlos Iribarren, Neil Risch, Aravinda Chakravarti	9
6	Meta-Analysis of 26 638 Individuals Identifies Two Genetic Loci Associated With Left Ventricular Ejection Fraction 2020 ·Circulation Genomic and Precision Medicine ·Hélène Choquet, Khanh K. Thai, J Chen, Dilrini K. Ranatunga, Thomas J. Hoffmann, Alan S. Go, Alistair C Lindsay, Margaret G. Ehm, Dawn Waterworth, Neil Risch, Catherine Schaefer	14
7	The impact of adjusting for baseline in pharmacogenomic genome-wide association studies of quantitative change 2020 ·npj Genomic Medicine ·Akinyemi Oni‐Orisan, Tanushree Haldar, Dilrini K. Ranatunga, Marisa W. Medina, Catherine Schaefer, Ronald M. Krauss, Carlos Iribarren, Neil Risch, Thomas J. Hoffmann	20
8	Associations of CYP2C9 and CYP2C19 Pharmacogenetic Variation with Phenytoin‐Induced Cutaneous Adverse Drug Reactions 2020 ·Clinical and Translational Science ·Alison E. Fohner, Allan E. Rettie, Khanh K. Thai, Dilrini K. Ranatunga, Brian L. Lawson, Jean‐Louis Vincent, Catherine Schaefer	13
9	Genome‐Wide Association and Functional Studies Reveal Novel Pharmacological Mechanisms for Allopurinol 2019 ·Clinical Pharmacology & Therapeutics ·Deanna J. Brackman, Sook Wah Yee, (unknown), Christian M. Shaffer, Dilrini K. Ranatunga, Joshua C. Denny, Wei‐Qi Wei, Yoichiro Kamatani, Michiaki Kubo, Dan M. Roden, Eric Jorgenson, Kathleen M. Giacomini	22
10	Assessing the clinical impact of CYP2C9 pharmacogenetic variation on phenytoin prescribing practice and patient response in an integrated health system 2019 ·Pharmacogenetics and Genomics ·Alison E. Fohner, Dilrini K. Ranatunga, Khanh K. Thai, Brian L. Lawson, Neil Risch, Akinyemi Oni‐Orisan, (unknown), Allan E. Rettie, Vincent X. Liu, Catherine Schaefer	9
11	Telomere length and socioeconomic status at neighborhood and individual levels among 80,000 adults in the Genetic Epidemiology Research on Adult Health and Aging cohort 2019 ·Environmental Epidemiology ·Stacey Alexeeff, Catherine Schaefer, Mark Kvale, Jun Shan, Elizabeth H. Blackburn, Neil Risch, Dilrini K. Ranatunga, Eric Jorgenson, Thomas J. Hoffmann, Lori C. Sakoda, Charles P. Quesenberry, Stephen K. Van Den Eeden	28
12	A large electronic-health-record-based genome-wide study of serum lipids 2018 ·Nature Genetics ·Thomas J. Hoffmann, Elizabeth Theusch, Tanushree Haldar, Dilrini K. Ranatunga, Eric Jorgenson, Marisa W. Medina, Mark Kvale, Pui–Yan Kwok, Catherine Schaefer, Ronald M. Krauss, Carlos Iribarren, Neil Risch	170
13	Characterization of Statin Low-Density Lipoprotein Cholesterol Dose-Response Using Electronic Health Records in a Large Population-Based Cohort 2018 ·Circulation Genomic and Precision Medicine ·Akinyemi Oni‐Orisan, Thomas J. Hoffmann, Dilrini K. Ranatunga, Marisa W. Medina, Eric Jorgenson, Catherine Schaefer, Ronald M. Krauss, Carlos Iribarren, Neil Risch	29
14	Association of LPA Variants With Aortic Stenosis 2017 ·JAMA Cardiology ·Hao Yu Chen, Line Dufresne, Hermann Burr, (unknown), (unknown), Kevin Luk, Dilrini K. Ranatunga, Rachel A. Whitmer, Mark Lathrop, James C. Engert, George Thanassoulis	43
15	Genome-wide association analyses using electronic health records identify new loci influencing blood pressure variation 2016 ·Nature Genetics ·Thomas J. Hoffmann, Georg Ehret, Priyanka Nandakumar, Dilrini K. Ranatunga, Catherine Schaefer, Pui–Yan Kwok, Carlos Iribarren, Aravinda Chakravarti, Neil Risch	192
16	B4-4: Genome-Wide Association Study of Macular Degeneration: Early Results from the Kaiser Permanente Research Program on Genes, Environment, and Health (RPGEH) 2013 ·Clinical Medicine & Research ·Eric Jorgenson, Stanley Sciortino, Ling Shen, Dilrini K. Ranatunga, Thomas J. Hoffmann, Mark Kvale, (unknown), Pui–Yan Kwok, Lutz Walter, Neil Risch, Catherine Schaefer	2
17	PS3-13: Re-Identification Risk Associated with Sharing Linked Genomic and Phenotypic Data from the Kaiser Permanente Research Program on Genes, Environment and Health (RPGEH) 2013 ·Clinical Medicine & Research ·Lutz Walter, Stanley Sciortino, Dilrini K. Ranatunga, (unknown), David Ludwig, Carol P. Somkin, (unknown), Catherine Schaefer	2
18	Clinical Implications of the Nelfinavir‐Proton Pump Inhibitor Drug Interaction in Patients with Human Immunodeficiency Virus 2011 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Parya Saberi, Dilrini K. Ranatunga, Charles P. Quesenberry, Michael J. Silverberg	7
19	Syphilis Epidemiology and Clinical Outcomes in HIV-Infected and HIV-Uninfected Patients in Kaiser Permanente Northern California 2009 ·Sexually Transmitted Diseases ·Michael A. Horberg, Dilrini K. Ranatunga, Charles P. Quesenberry, Daniel B. Klein, Michael J. Silverberg	32
20	Trihalomethane Exposures from Municipal Water Supplies and Selected Congenital Malformations 2003 ·Epidemiology ·Gary M. Shaw, Dilrini K. Ranatunga, Thu Quach, Eric Neri, Adolfo Correa, Raymond Neutra	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact